Aims Homeobox (Hox) proteins are transcriptional regulators in embryonic patterning, cell differentiation, proliferation, and migration in vertebrates and invertebrates. A growing body of evidence suggests that Hox proteins are involved in endothelial cell regulation. We have shown earlier that HoxB5 upregulates vascular endothelial growth factor receptor-2 and thereby contributes to enhanced endothelial precursor cell differentiation. Here we aim to elucidate the role of HoxB5 in angiogenesis.
Introduction
Hox genes are temporally and spatially restricted regulators of tissue patterning during embryonic development. They share a 60 amino acid DNA binding domain, the homeobox domain. Hox transcriptional regulators have been studied extensively in embryogenesis and they are known to regulate cell differentiation, proliferation, and migration in vertebrates and invertebrates. 1 As such they are excellent candidates to be involved in the transcriptional control of genes responsible for vascular remodelling and angiogenesis. 2 One of the most striking features of Hox genes is their clustered genomic arrangement and the remarkable colinearity of the expression pattern along the anterior-posterior axis with late positions (high-group numbers) expressed more caudally and earlier positions (low numbers) expressed more rostrally. 3, 4 As a result of cluster duplication each vertebrate Hox gene can have as many as three paralogues, each within an independent cluster (e.g. HoxA4, HoxB4, HoxC4, HoxD4; with the letters describing Hox genes in corresponding positions). 5 A growing body of evidence indicates that Hox transcription factors regulate genes involved in cell-cell and cellextracellular matrix (ECM) interactions, such as the expression of alphaV/beta3 integrin, matrix metalloproteinase-14 (MMP-14), or urokinase plasminogen activator receptor (uPAR). [6] [7] [8] [9] These proteins are involved in ECM remodelling which in turn is a prerequisite of angiogenesis. On the basis of their expression pattern in the pharyngeal arches, it has been hypothesized that the Hox3 genes are involved in blood vessel formation. Supporting a proangiogenic role of Hox3 genes, HoxA3 induces cell migration of endothelial and epithelial cells and thereby contributes to angiogenesis and wound repair. 8 Accordingly, HoxB3 increases vascular density and angiogenesis in the chick chorioallantoic membrane (CAM). Along the same line of evidence, HoxB3 promotes capillary morphogenesis and angiogenesis. 7 The third paralogue in the Hox3 cluster, HoxD3, also exerts proangiogenic effects in vitro and in vivo in the CAM assay and promotes invasive or migratory behaviour of endothelial cells. 6, 7 Finally, HoxD3-together with HoxA9-is involved in the angiogenic response of the histone methyltransferase MLL. 10 For some of the Hox genes, differential expression according to the state of endothelial activation and subsequent regulation of angiogenesis has been demonstrated. 11 The HoxB cluster is particularly promising to exert a role in blood vessel formation and homeostasis, because it plays a crucial role in the formation of paraxial mesoderm, the source of vascular precursor cells. 1 Taken together, these data clearly demonstrate that Hox genes may serve as regulatory factors that are important in blood vessel formation. During embryonic development both blood and blood vessels develop in close proximity and thus it is not surprising that the Hox4 group, being expressed adjacent to the Hox3 group, is crucial in hematopoesis. The next Hox group expressed more caudally is the Hox5 group.
In previous work, we identified HoxB5 as a transactivator of the intronic vascular endothelial growth factor receptor-2 (VEGFR-2) enhancer, a DNA sequence which is necessary for endothelial-specific expression of VEGFR-2. As a functional consequence, we found that stable overexpression of HoxB5 in differentiating embryonic stem cells (ES cells) resulted in increased numbers of endothelial precursor cells. 12 Thus, HoxB5 is directly involved in vasculogenesis. Additional data supporting this notion come from loss of function experiments in chick embryos in which knock down of all Hox5 paralogues resulted in a vascular phenotype. 13 On the basis of these findings, we now characterize the role of HoxB5 in angiogenesis. In the present work, we identify HoxB5 as an activator of blood vessel formation that acts by upregulation of angiopoietin-2 (Ang2).
Methods

Cell culture
Human umbilical vein endothelial cells (HUVECs) were isolated from human umbilical veins of newborns by collagenase digestion. Cells were cultured in a 378C incubator with 5% CO 2 in endothelial basal media supplemented with hydrocortisone, bovine brain extract, epidermal growth factor, and 10% FBS (EBM-1) and used for experiments until the 6th passage. Bovine aortic endothelial cells (BAECs) were purchased from Cambrex and cultured in DMEM supplemented with 10% FBS until the 14th passage at 378C and 5% CO 2 . All experiments were performed according to the principles outlined in the Declaration of Helsinki for the use of human tissue and according to regulations by the local Ethics Committee.
Adenoviral transduction
HoxB5 was cloned into a bicistronic expression plasmid with GFP expressed under the control of the second promoter serving as a transduction control. HoxB5 coding adenoviral particles (AdHoxB5) were produced in HEK 293 cells and purified by the virus core facility UNC Chapel Hill. As negative control adenoviral particles overexpressing only GFP (AdControl) were produced. Ang2 coding adenoviral particles (AdAng2) were a kind gift by Hellmut Augustin (German Cancer Research Centre, Heidelberg, Germany). HUVECs were cultured to 70% cellular confluency before adenovirus was added at a multiplicity of infection of 50 particles per cell.
Immunofluorescent detection of GFP revealed a transduction rate of virtually 100%.
Sprouting assay
HUVECs were suspended in endothelial cell growth medium (EGM; Cambrex), supplemented with 2% FBS, containing 0.20% (w/v) methylcellulose (Sigma), and seeded as drops (500 cells/25 mL) in non-adherent petri dishes (Greiner Bio-One). The dishes were incubated upside down as hanging drops for 24 h. Under these conditions, all suspended cells contribute to the formation of a single spheroid per drop of defined size and cell number (500 cells/spheroid). Afterwards, spheroids were harvested and resuspended in 20% EGM. Sedimentation of spheroids prior to polymerization of collagen gels was prevented by adding 0.80% (w/v) methylcellulose. This suspension was mixed with collagen type I which was pH adjusted to 7.4 by titration of 2.5% 1 N NaOH. The spheroid-containing collagen gel was rapidly transferred into 24-well plates and allowed to polymerize (20 min) and incubated for 24 h. In vitro angiogenesis was quantified by measuring the cumulative length of the sprouts that had grown out of each spheroid using digital imaging software (ADP-Soft; Olympus).
CAM assay
Fertilized white Leghorn chicken eggs were incubated in a humidified incubator at 37.88C and 67% humidity. At day 3 of development (E3), a window was cut into the eggshell and sealed again with adhesive plaster. The eggs were further incubated for 6 days. At E9, the window was opened and CAMs were transduced with AdHoxB5, AdAng2, or AdControl, respectively. Eggs were returned to the incubator for four more days, and at E13 CAMs were harvested and subjected to immunohistochemistry (for details, see 14 )
. Briefly, endothelial cells in CAM whole mounts were specifically stained with biotinylated Sambucus nigra lectin (Vector Laboratories) and Alexa546-conjugated streptavidin (Molecular Probes). Specimens were flat mounted and subjected to confocal microscopy (for details, see 14 ). Vascular phenotypes were analysed morphologically and quantified by counting vessel bifurcations.
RNA isolation and reverse transcription
Total RNA was extracted from HUVECs using the Aurum RNA Mini Kit (Bio-Rad). Reverse transcription was performed with the iScript cDNA-Kit (Bio-Rad) according to the manufacturer's instructions.
Semiquantitative PCR
Specific mRNA levels were determined by reverse transcription and semiquantitative PCR (Peqlab). For the RT-PCR analysis, the following sequence-specific primer pairs were used: Ang2 (forward primer: . The housekeeping gene hRP was used for internal normalization. Conditions for the PCR were 948C for 2 min followed by 30 cycles of 948C for 10 s, primerdependent annealing temperatures for 10 s (Ang2: 578C; HoxB5 and hRP: 628C), 728C for 30 s and as last step 5 min at 728C. Products were visualized by ethidium bromide on an agarose gel.
Quantitative PCR
Quantitative PCR (qPCR) in differentiating mouse ES cells was performed in a Perkin-Elmer 7700 TaqMan w PCR machine using the Applied Biosystems Prism 7000 sequence detection system, software, and reagents. Primers, reporter and quencher molecules specific for Ang1, Ang2, VEGF, HoxB5, GAPDH, and 18S rRNA as internal controls were purchased from Applied Biosystems. Expression of adhesion molecules was quantified using the real-time PCR detection system (Bio-Rad). Expression was calculated using the DDC T method. 
Western blot analysis
Cells were washed twice with ice-cold phosphate buffered saline, lysed on ice in RIPA buffer, and then centrifuged at 10 000 g for 10 min at 48C to remove insoluble material. The supernatant was collected and total cellular protein was quantified using Bradford protein assay (Bio-Rad). Equal amounts of protein were loaded and separated by a 12% SDS-PAGE. Electroblotting was performed to transfer proteins to a nitrocellulose membrane. After blocking with TBST, supplemented with non-fat dried milk, western blots were incubated overnight at 48C with antibodies against human Ang2 (1:1000, R&D) and b-Tubulin (1:3000, R&D). Secondary antibodies conjugated to horseradish peroxidase anti-goat IgG (1:2500) and anti-mouse IgG (1:2500) were purchased from R&D.
The membrane was incubated in the secondary antibody for 2 h and immunoreactive bands were detected using an ECL system (Amersham Bioscience).
Luciferase reporter gene assay
A variety of Ang2 promoter fragments were cloned into pGL3 basic using AY563557 as a template. BAECs were cultured to confluency of 60-80% and were then cotransfected with a HoxB5 expressing plasmid (pECH/HoxB5) and the respective Ang2-reporter construct or pGL3-basic (vector control) using Lipofectamine 2000 (Life Technologies). For internal normalization, BAECs were also cotransfected with pCMV/b-Gal (Clontech Laboratories) encoding for b-Galactosidase under the control of the CMV promoter. Transfections were performed in quadruplicates. After 16 h, cells were lysed and combined detection of luciferase, and b-Galactosidase was performed using the Dual-Light w System (Applied Biosystems) according to the manufacturer's protocol.
Statistical analysis
Results are expressed as mean + SEM and were analysed using the Wilcoxon rank sum test or the Mann-Whitney Test as appropriate. Differences were considered significant at P , 0.05.
Results
HoxB5 induces endothelial cell sprouting
We have shown earlier that the overexpression of HoxB5 drives ES cell differentiation along the endothelial cell path, resulting in enhanced vasculogenesis. 12 Accordingly, we now intended to examine whether HoxB5 was also involved in angiogenesis. To address this question, we performed a spheroid-based HUVEC sprouting assay. When HoxB5 was overexpressed in HUVECs, spheroid sprouting was increased when compared with transduction with control virus (Figure 1) . This finding suggests that the transcription factor HoxB5 initiates a proangiogenic program not only in ES cells but also in mature endothelial cells.
HoxB5 modifies adhesion molecule expression
To allow for an angiogenic response, endothelial cells have to partially detach from the underlying surface. In order to assess the effect of HoxB5 on endothelial cell adhesion, HUVECs were transduced with AdControl or AdHoxB5 and allowed to adhere on different matrices. Indeed, HoxB5 overexpression reduced the adhesive properties of endothelial cells independent of the extracellular matrix. To investigate potential effectors of HoxB5 in terms of endothelial cell sprouting, we studied the expression of a selection of adhesion molecules and proteinases (MMP-1, MMP-2, uPAR, alphaV, beta3, uPA). Indeed, we observed a strong upregulation of MMP-1. Also upregulated were: MMP-2, uPAR, and alphaV integrin. The expression of beta3 integrin and uPA was reduced (Figure 2) . These findings are consistent with the notion that overexpression of HoxB5 induces a proangiogenic response. 
HoxB5 and Ang2 modify intussusceptive angiogenesis in the chick CAM
Having shown that HoxB5 induces endothelial cell sprouting in vitro, we next aimed to investigate the effect of HoxB5 on angiogenesis in vivo. For this purpose, the angiogenic response to HoxB5 in the chick CAM assay was examined. In the CAM between E9 and E13, the capillary plexus expands by intussusceptive (non-sprouting) growth and adapts to haemodynamic changes via intussusceptive arborization and bifurcation remodelling.
15 Figure 3A and B demonstrates the anatomy of the CAM with the dense chorionic capillary network. In a cross section, the chorionic capillary network is located in close proximity to the chorionic surface of the CAM. En face views demonstrate the regular mesh structure of the capillary network. If AdControl virus was used to transduce the CAM, the chorionic capillary network remained unchanged ( Figure 3C ). When HoxB5 was adenovirally overexpressed in the CAM, the chorionic capillary network was transformed into a more arborized vascular tree ( Figure 3D ). These findings demonstrate that HoxB5 modifies non-sprouting angiogenesis in vivo by inhibiting capillary growth while promoting arborization.
The vascular phenotype that resulted from overexpression of HoxB5 ( Figure 3D ) was similar to the vascular phenotype induced by members of the angiopoietin family of proteins published by others. 16, 17 To assess, if the vascular phenotypes induced by Ang2 or HoxB5 were comparable in the same model, we adenovirally overexpressed Ang2 in the CAM and indeed observed a similar phenotype with a transformation of the capillary plexus into a ramified network of microvessels ( Figure 3E) . Accordingly, the number of bifurcations decreased to a similar degree upon Ang2 or HoxB5 ( Figure 3F ). With regard to endothelial cell sprouting, we were able to confirm previous reports that Ang2 increased endothelial cell sprouting ( Figure 1D) . 18 When Ang2 and HoxB5 were compared directly in the spheroid sprouting assay, we noticed very similar effects ( Figure 1C and E) . These findings prompted us to further investigate the relation between HoxB5 and Ang2 and to test the hypothesis that both act along the same pathway.
Ang2 is upregulated by HoxB5
To address the question, if Ang2 was regulated by HoxB5 HUVECs were transduced with AdHoxB5 or AdControl and Ang2 was quantified. Indeed, we found that HoxB5 upregulated Ang2 RNA transcription as shown by RT-PCR. Ang2 protein was also increased in the supernatant of HoxB5 overexpressing cells ( Figure 4A and B) . Thus, the complimentary phenotypes observed in the angiogenesis assays may be explained by a regulation of Ang2 by HoxB5.
HoxB5 specifically regulates Ang2
To assess if HoxB5 upregulated Ang2 specifically, we compared the expression response of Ang2 with Ang1 and VEGF by qPCR. In HoxB5 overexpressing cells, Ang2 was highly upregulated, whereas Ang1 and VEGF expression was only slightly increased ( Figure 5) . In order to ascertain the dose dependency of the HoxB5 overexpression, we compared cells expressing HoxB5 at different levels. Indeed, high levels of HoxB5 resulted in a much more pronounced upregulation of Ang2 compared with lower HoxB5 levels. Thus, HoxB5 specifically regulates Ang2 in a dose-dependent manner. 
HoxB5 indirectly induces the Ang2 promoter
Our in vitro and in vivo data presented above indicate that HoxB5 regulates the expression of Ang2. To investigate the interaction of HoxB5 with the Ang2 promoter in detail, we used a luciferase expression system under the control of different Ang2 promoter fragments. Depending on the length of the Ang2 promoter fragment used, HoxB5 strongly induced the Ang2 promoter. We confirmed the presence of distal repressive elements between -3519 and -2119 bp as published earlier. 19 Interestingly, there was a significant decrease in Ang2 promoter activity in response to HoxB5 between the promoter fragments containing 107 bp upstream of the transcriptional start site and the promoter fragment containing 54 bp upstream of the transcriptional start site. This suggests that the sequence between 2107 and 254 significantly contributes to the effect of HoxB5 on Ang2 expression ( Figure 6A ). In silico analysis does not predict direct interaction between HoxB5 and the DNA contained in this element. Consistently, we were not able to demonstrate HoxB5 binding to this sequence in EMSA suggesting an indirect effect of HoxB5 on the Ang2 promoter (data not shown).
HoxB5-induced angiogenesis is Ang2-dependent
On the basis of the regulation of Ang2 by HoxB5 and their similar vascular phenotypes, we hypothesized that the HoxB5 effect on endothelial cells might be conferred by Ang2. To address this question, we used the specific angiopoietin inhibitor sTie-2 to block Ang2 activity. Indeed, when endothelial cells were transduced with AdHoxB5 in the presence of sTie-2, the effect of HoxB5 was abolished and endothelial cell sprouting was blocked (Figure 7) . These data confirm the notion that Ang2 is a mediator of the angiogenesis modulating effect induced by HoxB5.
Discussion
Angiogenesis is crucial during embryonic development and in adulthood. The regulation of blood vessel formation is complex and far from being understood. We have previously shown that HoxB5, a member of the Hox family of transcription factors, is involved in the differentiation of ES cells into vascular precursor cells. 12 Here, we present in vitro and in vivo evidence that HoxB5 is also a modifier of angiogenesis. In accordance to the finding that in ES cell differentiation overexpression of HoxB5 stimulates the formation and growth of endothelial precursor cells, HoxB5 activates angiogenic sprouting of cultured endothelial cells (Figure 1) . It is well known that for effective sprouting endothelial cells have to partially detach from the underlying surface to allow for cell dislocation. Migrating cells develop polarity and establish adhesion in one area and detach from the extracellular matrix in another. When endothelial cell adhesion was quantified on various matrices, we found that overexpression of HoxB5 decreases cell adhesion. Along the same lines of evidence, we detected an orchestrated expressional response of adhesion molecules upon stimulation with HoxB5. Matrixmetalloproteinases-1 and -2 are upregulated resulting in increased extracellular matrix degradation which in turn contributes to facilitate cell sprouting. At the same time, beta3 integrin is downregulated, a process that potentially results in the detachment of the cell from its underlying matrix (Figure 2) . On the basis of these in vitro experiments, the chick CAM assay was used to confirm the angiogenesis modulating activity of HoxB5 in vivo (Figure 3 ). When HoxB5 was overexpressed in the developing CAM, the chorionic capillary network was transformed into a more arborized vascular tree. Indeed, the formation and arborization of capillaries in the CAM after E9 is controlled by intussusceptive growth which describes a mechanism of blood vessel generation and remodelling by the formation of transluminal pillars. 15 The shape of these pillars is maintained by endothelial cells and pericytes.
14 The pillars may grow in size and number as well as they may merge with adjacent pillars to form folds and finally shape new vascular branches. 15 Interestingly, intussusceptive vascular growth and remodelling are regulated by classical vascular growth factors such as VEGF, 20 PDGF-B, 21 the angiopoietins, and their Tie receptors. 22 Particularly for intussusceptive growth, a wellorchestrated and fine-tuned cooperation between these growth factors is essential. 23 Such a coordinated control may be achieved by the regulation through upstream transcription factors. The data presented in this manuscript together with our earlier findings suggest that HoxB5 may be such a regulatory transcription factor in vascular growth and particularly in intussusceptive vascular growth.
The vascular phenotype induced by HoxB5 is very reminiscent of the phenotypes induced by members of the angiopoietin family. [16] [17] [18] 24 We therefore directly compared the effects of HoxB5 with the effects of Ang2. As shown in Figure 3E and F (in vivo CAM assay) as well as in Figure 1C and D (in vitro endothelial cell sprouting), we obtained similar effects for both agonists. This led us to hypothesize that Ang2 may act downstream of HoxB5. Indeed, HUVECs that have been transduced to overexpress HoxB5 produce more Ang2 RNA and protein (Figure 4) . According to our notion that a well-orchestrated regulation of growth factors is necessary to coordinate intussusceptive vascular growth, we found that Ang1 and VEGF are upregulated by HoxB5 to a substantially lower extent than Ang2 ( Figure 5 ). Thus taking into consideration our previous findings, we conclude from this set of experiments that HoxB5 upregulates not only VEGFR-2, 12 a factor that facilitates an angiogenic response of endothelial cells, but also increases Ang2 which has been described to destabilize existing endothelial networks, a prerequisite for vascular remodelling. 25 However, Ang2 may act as agonist or as antagonist at the Tie2 receptor 23 and the combination of available data 19, 23, [25] [26] [27] [28] does not suggest a clear-cut antior proangiogenic effect but rather a modifying role. Such a modification could correspond to the transformation of capillary meshes into a ramified network by switching from intussusceptive microvascular growth to arborization and bifurcation remodelling in the CAM. We demonstrate the functional relevance of Ang2 in the response of endothelial cells to HoxB5 by using the angiopoietin specific inhibitor sTie-2 ( Figure 7) . Indeed, sTie-2 abolishes the proangiogenic effect of HoxB5 suggesting that the role of angiopoietins not only in angiogenic sprouting but also in intussusceptive growth is essential and is not compensated for by other potential downstream mediators of HoxB5.
To investigate the effect of HoxB5 on Ang2 expression in more detail, we dissected the Ang2 promoter. By deletion analysis, we found a 53 bp element in the proximal Ang2 promoter that was responsive to HoxB5 ( Figure 6 ). In silico analysis does not predict a canonical HoxB5 binding sequence within this element, and consistently our data does not suggest a direct interaction between HoxB5 and the Ang2 promoter with this element. One may speculate that transcriptional cofactors to HoxB5 may be necessary for DNA binding, although our data are not in favour of this notion. It appears more likely that other not yet identified regulators act along the pathway between HoxB5 and Ang2.
Among the reported studies of Hox genes in vascular biology, the overwhelming majority of experiments have been performed under conditions under which the respective Hox transcription factor was overexpressed. It is noteworthy that gene deletion studies of Hox genes in many cases were not useful to study cardiovascular defects most likely because other Hox genes from the same paralogous group or even from the same cluster may have compensated for the loss. 29, 30 For example, genetic deletion of Hox3 genes does not result in a detectable cardiovascular phenotype, although overexpression of these genes has proangiogenic effects. 31, 32 Moreover, studies in Drosophila suggest that the more posteriorly expressed Hox genes usually impose their function over that of more anterior genes ('posterior prevalence') through a suppressive mechanism that does not involve transcriptional repression. 33 This is particularly true for the lack of function situation. Therefore, we decided to take the approach to overexpress and not to suppress HoxB5 in this study.
Taken together, HoxB5 is a modifying regulator in the finetuned orchestration of the angiogenic response of endothelial cells. Upregulation of Ang2 is the key downstream event of HoxB5 in angiogenesis and is essential to confer endothelial cell activation by HoxB5.
